Polynovo Stock

Polynovo ROA 2024

Polynovo ROA

0.05

Ticker

PNV.AX

ISIN

AU000000PNV0

WKN

A12F4T

In 2024, Polynovo's return on assets (ROA) was 0.05, a -241.91% increase from the -0.03 ROA in the previous year.

Polynovo Aktienanalyse

What does Polynovo do?

Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Polynovo's Return on Assets (ROA)

Polynovo's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Polynovo's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Polynovo's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Polynovo’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Polynovo stock

What is the Return on Assets (ROA) of Polynovo this year?

The Return on Assets (ROA) of Polynovo is 0.05 undefined this year.

What was the ROA of Polynovo compared to the previous year?

The ROA of Polynovo has increased by -241.91% compared to the previous year.

What consequences do high ROA have for investors of Polynovo?

A high ROA is advantageous for investors of Polynovo, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Polynovo?

A low ROA can be unfavorable for investors of Polynovo as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Polynovo affect the company?

An increase in ROA of Polynovo can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Polynovo impact the company?

A reduction in the ROA of Polynovo can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Polynovo?

Some factors that can influence the ROA of Polynovo include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Polynovo important for investors?

The ROA of Polynovo is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Polynovo take to improve ROA?

To improve ROA, Polynovo can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Polynovo pay?

Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.

What is the dividend yield of Polynovo?

The current dividend yield of Polynovo is .

When does Polynovo pay dividends?

Polynovo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Polynovo?

Polynovo paid dividends every year for the past 0 years.

What is the dividend of Polynovo?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Polynovo located?

Polynovo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Polynovo from 12/19/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Polynovo pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Polynovo in the year 2023?

In the year 2023, Polynovo distributed 0 AUD as dividends.

In which currency does Polynovo pay out the dividend?

The dividends of Polynovo are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Polynovo

Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.